Life Molecular Imaginglmiis An International Pharmaceutical Company Based In Matranswitzerlandfounded In 2012Lmi Specializes In Developing And Commercializing Molecular Imaging Tracersparticularly Positron Emission Tomographypetradiopharmaceuticalsthe Company Aims To Meet Significant Clinical Needs In Neurology And Cardiologyproviding Valuable Insights For Improved Diagnosis And Personalized Patient Care Lmi Operates Research And Development Laboratories To Create Novel Pet Tracers And Maintains A Network Of Cyclotrons And Radiopharmacies For The Production And Distribution Of Radiopharmaceuticalsthey Also Offer Access To Imaging Facilities For Clinical Trials And Routine Diagnosticsone Of Their Key Products Is Neuraceqdesigned For Imaging Neurodegenerative Conditionsand They Have A Promising Pipeline Of Products Targeting Neurodegenerative And Cardiovascular Diseases Lmi Serves A Diverse Clienteleincluding Physiciansthe Pharmaceutical Industryand Academic Institutionsand Collaborates With Partners In The Molecular Imaging Fieldtheir Mission Focuses On Pioneering Innovative Pet Products To Enhance Early Detection And Treatment Of Chronic Diseasesultimately Improving Patient Outcomes And Quality Of Life
No conferences found for this company.
| Company Name | Piramal Imaging Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
